A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis

Completed · Phase 3

Conditions studied: Multiple Sclerosis

In brief

The purpose of the trial is to determine the safety and efficacy of RPC1063 in patients with relapsing multiple sclerosis.

Key facts

Study ID

NCT02576717

Run by

Celgene

People needed

2494

Starts

2015-10-16

Expected to finish

2023-01-05

Last updated by the study team

2024-01-30

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Local Institution - 118 — Phoenix, Arizona, United States
• Local Institution - 110 — Berkeley, California, United States
• Local Institution - 103 — Fresno, California, United States
• Local Institution - 122 — Long Beach, California, United States
• Local Institution - 112 — Sacramento, California, United States
• Local Institution - 120 — San Francisco, California, United States
• Local Institution - 114 — Maitland, Florida, United States
• Local Institution - 123 — Port Charlotte, Florida, United States
• Local Institution - 124 — Sunrise, Florida, United States
• Local Institution - 147 — Tampa, Florida, United States
• Local Institution - 137 — Golden Valley, Minnesota, United States
• Local Institution - 170 — Las Vegas, Nevada, United States
• Local Institution - 143 — Raleigh, North Carolina, United States
• Local Institution - 107 — Westerville, Ohio, United States
• Local Institution - 144 — Knoxville, Tennessee, United States
• Local Institution - 138 — Lubbock, Texas, United States
• Local Institution - 179 — Round Rock, Texas, United States
• Local Institution - 141 — Kirkland, Washington, United States
• Local Institution - 907 — Grodno, Belarus
• Local Institution - 904 — Homyel, Belarus
• Local Institution - 902 — Minsk, Belarus
• Local Institution - 901 — Minsk, Belarus
• Local Institution - 903 — Minsk, Belarus
• Local Institution - 905 — Vitebsk, Belarus
• Local Institution - 115 — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.